XML 11 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONSOLIDATED STATEMENTS OF CASHFLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
OPERATING ACTIVITIES    
Net income $ 871,987 $ 514,803
Net income/(loss) from continuing operations 951,268 (89,144)
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 39,328 41,592
Impairment of long-lived assets 76,155 0
Net (income)/loss from equity method investments (12,996) 562
Change in fair value of investment in listed equity securities (346,497) 244,210
FINANCING ACTIVITIES    
Cash, cash equivalents and restricted cash within assets held for sale at the beginning of period 80,507 64,749
Cash, cash equivalents and restricted cash within assets held for sale at end of period 41 74,791
Net increase/(decrease) in cash within assets held for sale 80,466 (10,042)
Net increase/(decrease) in cash, cash equivalents, restricted cash and cash within assets held for sale 290,829 (32,744)
Cash, cash equivalents and restricted cash at beginning of period 338,284 226,124
Cash, cash equivalents and restricted cash at end of period 629,113 193,380
Supplemental Cash Flow Information [Abstract]    
Cash and cash equivalents 498,164 91,084
Restricted cash and short-term deposits 19,025 30,247
Restricted cash 111,924 72,049
Cash, cash equivalents, restricted cash and restricted cash equivalents 629,113 193,380
Continuing operations    
OPERATING ACTIVITIES    
Net income/(loss) from continuing operations 951,268 (89,144)
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 39,328 41,592
Amortization of deferred charges and debt guarantees, net 1,642 1,107
Impairment of long-lived assets 76,155 0
Net (income)/loss from equity method investments (12,996) 562
Compensation cost related to employee stock awards 2,455 2,445
Net foreign exchange losses/(gains) (1,536) 654
Change in fair value of investment in listed equity securities (346,497) 244,210
Changes in assets and liabilities:    
Trade accounts receivable (20,951) (2,605)
Inventories (209) 75
Other current and non-current assets (36,575) 4,184
Amounts due from/to related companies (3,568) (9,269)
Trade accounts payable 3,325 (3,379)
Accrued expenses (205) (13,827)
Other current and non-current liabilities (53,515) 67,845
Net cash provided by continuing operating activities 141,792 73,347
INVESTING ACTIVITIES    
Additions to assets under development (220,354) (183,305)
Additions to equity method investments 0 (8,625)
Additions to other investments (2,447) 0
Proceeds from subscription of equity interest in Gimi MS 26,903 16,872
Proceeds from sale of listed equity securities 252,960
Dividends received from listed equity securities 4,908 3,725
Net cash provided by/(used in) continuing investing activities 61,970 (171,333)
FINANCING ACTIVITIES    
Proceeds from short-term and long-term debt 258,287 112,848
Net debt repayments (534,294) (70,325)
Cash dividends paid (39,293) (24,437)
Financing costs paid (8,960) (4,599)
Purchase of treasury shares (20,358) (24,484)
Proceeds from exercise of share options 161 0
Net cash used in continuing financing activities (344,457) (10,997)
Discontinued operations    
OPERATING ACTIVITIES    
Add: Net (income)/loss from discontinued operations 79,281 (603,947)
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation and amortization 8,699 37,895
Amortization of deferred charges and debt guarantees, net 3,932 895
Net (income)/loss from equity method investments 0 6,891
Compensation cost related to employee stock awards 239 618
Net foreign exchange losses/(gains) 574 160
Changes in assets and liabilities:    
Trade accounts receivable 437 3,312
Inventories 0 380
Other current and non-current assets (5,536) 276
Amounts due from/to related companies (804) 0
Trade accounts payable (7,285) 2,915
Accrued expenses (4,946) 14,378
Other current and non-current liabilities (22,105) 718
Drydocking expenditure 0 (1,591)
Deconsolidation of lessor VIEs (59,085) 0
(Gain)/loss on disposal and impairment of long-lived assets 105,201 (575,056)
Net cash (used in)/provided by discontinued operating activities (59,960) 95,738
INVESTING ACTIVITIES    
Dividends received from listed equity securities 0 460
Additions to vessels and equipment 0 (925)
Net proceeds from disposals of equity method investments 0 119,560
Net proceeds from disposals of long-lived assets 569,298 0
Net cash provided by discontinued investing activities 569,298 119,095
FINANCING ACTIVITIES    
Proceeds from short-term and long-term debt 0 10,073
Net debt repayments (158,000) (137,925)
Financing costs paid (280) (700)
Net cash used in discontinued financing activities (158,280) (128,552)
Interest rate swap | Continuing operations    
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Change in fair value of derivative instruments (interest rate swaps) (74,915) (18,557)
Oil and gas derivative | Continuing operations    
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Change in fair value of derivative instruments (interest rate swaps) $ (381,414) $ (152,546)